Clin Chim Acta 204:263277 Hoffmann GF, Athanassopoulos S, Burlina AB, Duran M, de Klerk JB, Lehnert W, Leonard JV, Monavari AA, Muller E, Muntau AC, Naughten ER, Plecko-Starting B, Superti-Furga A, Zschocke J, Christensen E (1996) Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency
Bottom line: MeAgain connects food, protein, fiber, water, symptoms, and dose context instead of making nutrition another disconnected task
Reduced Fat Mass: Preclinical studies have shown significant reductions in white adipose tissue
What makes Epitalon intriguing in the oncology space is not that it targets tumors directly, but that it appears to stabilize genomic integrity that allows cancer to flourish in the first place